Metropolitan Life Insurance CO Aldeyra Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$2.77 - $4.22 $55 - $84	20 Added 11.3%	197 $0
Q4 2023 Feb 14, 2024	SELL	$1.47 - $6.06 $3,500 - $14,428	-2,381 Reduced 93.08%	177 $0
Q2 2023 Aug 10, 2023	BUY	$7.11 - $11.89 $18,187 - $30,414	2,558 New	2,558 $21,000
Q2 2022 Aug 11, 2022	SELL	$2.43 - $4.85 $8,675 - $17,314	-3,570 Closed	0 $0
Q1 2022 Jun 20, 2023	BUY	$3.25 - $5.17 $11,602 - $18,456	3,570 New	3,570 $15,000
Q1 2022 Mar 30, 2023	SELL	$3.25 - $5.17 $5,820 - $9,259	-1,791 Reduced 33.41%	3,570 $15,000
Q1 2022 May 12, 2022	SELL	$3.25 - $5.17 $5,820 - $9,259	-1,791 Reduced 33.41%	3,570 $16,000
Q4 2021 Jun 21, 2023	BUY	$3.5 - $9.63 $18,763 - $51,626	5,361 New	5,361 $21,000
Q4 2021 Mar 30, 2023	SELL	$3.5 - $9.63 $13,062 - $35,939	-3,732 Reduced 41.04%	5,361 $21,000
Q4 2021 Feb 15, 2022	SELL	$3.5 - $9.63 $13,062 - $35,939	-3,732 Reduced 41.04%	5,361 $21,000
Q3 2021 Jun 21, 2023	BUY	$7.94 - $11.31 $72,198 - $102,841	9,093 New	9,093 $79,000
Q3 2021 Mar 30, 2023	SELL	$7.94 - $11.31 $43,566 - $62,057	-5,487 Reduced 37.63%	9,093 $79,000
Q3 2021 Nov 15, 2021	SELL	$7.94 - $11.31 $43,566 - $62,057	-5,487 Reduced 37.63%	9,093 $80,000
Q2 2021 Jun 21, 2023	BUY	$10.44 - $14.85 $152,215 - $216,513	14,580 New	14,580 $165,000
Q2 2021 Mar 30, 2023	BUY	$10.44 - $14.85 $152,215 - $216,513	14,580 New	14,580 $165,000
Q2 2021 Aug 16, 2021	BUY	$10.44 - $14.85 $152,215 - $216,513	14,580 New	14,580 $165,000

116

36.2M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $285M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.